In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Shenzhen Hepalink Pharma goes public

Executive Summary

In the highest ever IPO done on China's A-share market, Shenzhen Hepalink Pharmaceutical Co. Ltd. (manufactures heparin) has raised Yuan Renminbi 5.9bn ($868mm) through the sale of 40.1mm shares for Yuan Renminbi 148 apiece.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies